Hypertension

An overactive stress response contributes to the development of insulin resistance in obese individuals, and blocking it may be therapeutically beneficial. Read More

Vanderbilt researchers have discovered that certain immune cells contribute to the development of hypertension, suggesting novel targets for treating the disease. Read More

Hypertension Clinic members include, from left, Sandy Berryhill, LPN, Lynn Christman, Cheryl Laffer, M.D., Matt Luther, M.D., Fernando Elijovich, M.D., Robert Manning, R.N., and Karen Gore, R.N. (Not pictured: Nancy Brown, M.D., Barb Dotson, R.N., and Mena Mangrum, LPN. The American Society of Hypertension (ASH) has… Read More

Clinical pharmacologist Jens Titze, M.D., and his colleagues have identified a new cast of cells and molecules that function in the skin to control sodium balance and blood pressure. Read More

Cheryl Laffer, M.D., PhD., professor of Medicine, is the new director of the Hypertension Service within the Division of Clinical Pharmacology. Read More

A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome. Read More

Some patients may need a combo of medications to combat a condition that causes dizziness. Read More

About half of kidney patients will die from heart disease within five years of starting dialysis, yet patients with kidney failure are rarely included in heart disease research. Jorge Gamboa, M.D., T. Alp Ikizler, M.D., and Nancy Brown, M.D., completed a small study that suggests a more personalized approach to… Read More

Vanderbilt University Medical Center investigators have demonstrated that dopamine produced outside the brain – in the kidneys – is important for renal function, blood pressure regulation and life span. Read More